Elevance Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	198,313	197,584	175,204	170,209	155,660	136,943
Revenue Growth (YoY)	9.14%	12.77%	2.94%	9.35%	13.67%	13.36%
Cost of Revenue	170,184	169,401	147,317	141,623	129,677	113,466
Gross Profit	28,129	28,183	27,887	28,586	25,983	23,477
Depreciation & Amortization Expenses	585	628	580	885	767	441
Other Operating Expenses	22,014	20,984	20,025	20,087	17,700	15,918
Total Operating Expenses	22,599	21,612	20,605	20,972	18,467	16,359
Operating Income	5,530	6,571	7,282	7,614	7,516	7,118
Interest Income	2,369	2,194	2,051	1,825	1,485	1,378
Interest Expense	-1,415	-1,402	-1,185	-1,030	-851	-798
Other Non-Operating Income (Expense)	-267	-653	-244	-694	-550	297
Total Non-Operating Income (Expense)	687	139	622	101	84	877
Pretax Income	6,217	6,710	7,904	7,715	7,600	7,995
Provision for Income Taxes	980	1,049	1,933	1,724	1,712	1,846
Net Income	5,237	5,661	5,971	5,991	5,888	6,149
Minority Interest in Earnings	-3	-1	-9	4	-6	-9
Net Income to Common	5,243	5,662	5,980	5,987	5,894	6,158
Net Income Growth	-11.39%	-5.32%	-0.12%	1.58%	-4.29%	34.69%
Shares Outstanding (Basic)	223	224	232	236	240	244
Shares Outstanding (Diluted)	223	225	233	237	243	247
Shares Change (YoY)	-3.58%	-3.56%	-1.90%	-2.22%	-1.62%	-2.95%
EPS (Basic)	23.56	25.28	25.81	25.38	24.56	25.26
EPS (Diluted)	23.51	25.21	25.68	25.22	24.28	24.95
EPS Growth	-8.27%	-1.83%	1.82%	3.87%	-2.69%	38.77%
Free Cash Flow	6,450	3,174	4,552	6,765	7,247	7,277
Free Cash Flow Growth	103.21%	-30.27%	-32.71%	-6.65%	-0.41%	-24.72%
Free Cash Flow Per Share	28.93	14.13	19.54	28.50	29.85	29.49
Dividends Per Share	6.850	6.840	6.520	5.920	5.120	4.520
Dividend Growth	0.15%	4.91%	10.13%	15.63%	13.27%	18.95%
Gross Margin	14.18%	14.26%	15.92%	16.79%	16.69%	17.14%
Operating Margin	2.79%	3.33%	4.16%	4.47%	4.83%	5.20%
Profit Margin	2.64%	2.87%	3.41%	3.52%	3.78%	4.49%
FCF Margin	3.25%	1.61%	2.60%	3.97%	4.66%	5.31%
EBITDA	7,256	8,316	8,828	9,007	9,191	8,420
EBITDA Margin	3.66%	4.21%	5.04%	5.29%	5.90%	6.15%
EBIT	5,530	6,571	7,282	7,614	7,516	7,118
EBIT Margin	2.79%	3.33%	4.16%	4.47%	4.83%	5.20%
Effective Tax Rate	15.76%	15.63%	24.46%	22.35%	22.53%	23.09%

SEC Filings: 10-K · 10-Q